
KaloCyte
Developer of red blood cell substitutes designed for trauma care-related services. The company's cell substitutes are designed for context-dependent oxygen delivery, while minimizing vasoconstriction ...
Valuation
$0
Share Price
N/A
Total Raised
$5.7M
Last Round
N/A